Stock Analysts’ price target changes for Friday, August 14th:
Adeia (NASDAQ:ADEA) had its target price boosted by BWS Financial from $30.00 to $50.00. They currently have a buy rating on the stock.
Aebi Schmidt (NASDAQ:AEBI) had its price target raised by DA Davidson from $15.00 to $17.00. They currently have a buy rating on the stock.
Applied Industrial Technologies (NYSE:AIT) had its target price boosted by DA Davidson from $380.00 to $400.00. The firm currently has a buy rating on the stock.
Applied Industrial Technologies (NYSE:AIT) had its price target boosted by Robert W. Baird from $317.00 to $400.00. Robert W. Baird currently has an outperform rating on the stock.
Applied Industrial Technologies (NYSE:AIT) had its price target increased by Mizuho from $355.00 to $400.00. They currently have an outperform rating on the stock.
Alliance Laundry (NYSE:ALH) had its price target raised by Robert W. Baird from $32.00 to $34.00. The firm currently has an outperform rating on the stock.
Alliance Laundry (NYSE:ALH) had its target price increased by JPMorgan Chase & Co. from $31.00 to $32.00. The firm currently has an overweight rating on the stock.
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its target price cut by Wells Fargo & Company from $316.00 to $256.00. The firm currently has an equal weight rating on the stock.
Applied Materials (NASDAQ:AMAT) had its target price boosted by Royal Bank Of Canada from $520.00 to $600.00. They currently have an outperform rating on the stock.
Applied Materials (NASDAQ:AMAT) had its price target raised by JPMorgan Chase & Co. from $515.00 to $660.00. They currently have an overweight rating on the stock.
Amcor (NYSE:AMCR) had its price target increased by Wells Fargo & Company from $43.00 to $44.00. Wells Fargo & Company currently has an equal weight rating on the stock.
AMN Healthcare Services (NYSE:AMN) had its target price boosted by Citizens Jmp from $36.00 to $40.00. They currently have a market outperform rating on the stock.
Antofagasta (LON:ANTO) had its target price cut by JPMorgan Chase & Co. from GBX 4,500 to GBX 4,300. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Appian (NASDAQ:APPN) had its price target raised by DA Davidson from $34.00 to $42.00. The firm currently has a neutral rating on the stock.
Aveanna Healthcare (NASDAQ:AVAH) had its price target raised by BMO Capital Markets from $10.00 to $14.00. BMO Capital Markets currently has an outperform rating on the stock.
Barrick Mining (NYSE:B) (TSE:ABX) had its target price increased by JPMorgan Chase & Co. from $50.00 to $52.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) had its target price reduced by JPMorgan Chase & Co. from $27.00 to $25.00. They currently have an overweight rating on the stock.
Bullish (NYSE:BLSH) had its price target reduced by JPMorgan Chase & Co. from $26.00 to $25.00. The firm currently has a neutral rating on the stock.
Bullish (NYSE:BLSH) had its price target trimmed by Rosenblatt Securities from $42.50 to $30.00. The firm currently has a neutral rating on the stock.
Brookfield (NYSE:BN) had its price target raised by Scotiabank from $53.00 to $54.00. They currently have a sector outperform rating on the stock.
Bending Spoons (NASDAQ:BSP) had its price target boosted by JPMorgan Chase & Co. from $35.00 to $38.00. The firm currently has a neutral rating on the stock.
Bending Spoons (NASDAQ:BSP) had its price target boosted by Benchmark Co. from $45.00 to $50.00. They currently have a buy rating on the stock.
BTGO (NYSE:BTGO) had its price target lowered by Mizuho from $14.00 to $11.00. The firm currently has an outperform rating on the stock.
Cabaletta Bio (NASDAQ:CABA) had its price target trimmed by Wells Fargo & Company from $4.00 to $3.00. The firm currently has an equal weight rating on the stock.
Celcuity (NASDAQ:CELC) had its price target trimmed by Stifel Nicolaus from $175.00 to $150.00. They currently have a buy rating on the stock.
Celcuity (NASDAQ:CELC) had its target price reduced by Needham & Company LLC from $157.00 to $140.00. The firm currently has a buy rating on the stock.
Cellebrite DI (NASDAQ:CLBT) had its price target cut by Needham & Company LLC from $15.00 to $12.50. Needham & Company LLC currently has a buy rating on the stock.
Cellebrite DI (NASDAQ:CLBT) had its target price cut by DA Davidson from $22.00 to $15.00. The firm currently has a buy rating on the stock.
Cellebrite DI (NASDAQ:CLBT) had its target price cut by JPMorgan Chase & Co. from $20.00 to $16.00. They currently have an overweight rating on the stock.
Costain Group (LON:COST) had its price target increased by Berenberg Bank from GBX 240 to GBX 275. Berenberg Bank currently has a buy rating on the stock.
Creative Realities (NASDAQ:CREX) had its target price raised by LADENBURG THALM/SH SH from $7.50 to $8.00. They currently have a buy rating on the stock.
CorMedix (NASDAQ:CRMD) had its price target raised by Royal Bank Of Canada from $13.00 to $14.00. The firm currently has an outperform rating on the stock.
Cousins Properties (NYSE:CUZ) had its target price increased by Robert W. Baird from $33.00 to $35.00. They currently have an outperform rating on the stock.
Deere & Company (NYSE:DE) had its price target lowered by JPMorgan Chase & Co. from $590.00 to $570.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Dynatrace (NYSE:DT) had its price target boosted by Truist Financial Corporation from $55.00 to $60.00. They currently have a buy rating on the stock.
Brinker International (NYSE:EAT) had its price target raised by Bank of America Corporation from $224.00 to $310.00. The firm currently has a buy rating on the stock.
Eikon Therapeutics (NASDAQ:EIKN) had its price target trimmed by Wedbush from $5.00 to $4.00. Wedbush currently has an underperform rating on the stock.
Embraer-Empresa Brasileira de Aeronautica (NYSE:EMBJ) had its price target raised by JPMorgan Chase & Co. from $80.00 to $104.00. The firm currently has an overweight rating on the stock.
Eos Energy Enterprises (NASDAQ:EOSE) had its target price lowered by B. Riley Financial, Inc. from $8.00 to $5.00. The firm currently has a neutral rating on the stock.
Essentra (LON:ESNT) had its price target trimmed by Berenberg Bank from GBX 160 to GBX 140. Berenberg Bank currently has a buy rating on the stock.
Essex Property Trust (NYSE:ESS) had its target price increased by JPMorgan Chase & Co. from $275.00 to $295.00. They currently have an underweight rating on the stock.
enCore Energy (NASDAQ:EU) had its target price cut by HC Wainwright from $3.75 to $3.50. HC Wainwright currently has a buy rating on the stock.
Funding Circle (LON:FCH) had its target price raised by Deutsche Bank Aktiengesellschaft from GBX 190 to GBX 290. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.
Fold (NASDAQ:FLD) had its target price reduced by Cantor Fitzgerald from $1.70 to $0.70. The firm currently has an overweight rating on the stock.
Golar LNG (NASDAQ:GLNG) had its price target boosted by BTIG Research from $67.00 to $70.00. BTIG Research currently has a buy rating on the stock.
Globant (NYSE:GLOB) had its target price trimmed by Guggenheim from $55.00 to $50.00. They currently have a buy rating on the stock.
Globant (NYSE:GLOB) had its target price cut by The Goldman Sachs Group, Inc. from $60.00 to $52.00. They currently have a neutral rating on the stock.
Globant (NYSE:GLOB) had its price target trimmed by JPMorgan Chase & Co. from $47.00 to $44.00. The firm currently has a neutral rating on the stock.
Globant (NYSE:GLOB) had its target price reduced by TD Cowen from $47.00 to $45.00. They currently have a buy rating on the stock.
The Gym Group (LON:GYM) had its price target raised by Berenberg Bank from GBX 255 to GBX 295. Berenberg Bank currently has a buy rating on the stock.
Honeywell International (NASDAQ:HON) had its target price cut by JPMorgan Chase & Co. from $262.00 to $255.00. The firm currently has an overweight rating on the stock.
Hormel Foods (NYSE:HRL) had its target price boosted by JPMorgan Chase & Co. from $25.00 to $26.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Heartflow (NASDAQ:HTFL) had its price target raised by JPMorgan Chase & Co. from $35.00 to $45.00. The firm currently has an overweight rating on the stock.
Heartflow (NASDAQ:HTFL) had its price target boosted by Wells Fargo & Company from $37.00 to $39.00. The firm currently has an overweight rating on the stock.
Heartflow (NASDAQ:HTFL) had its price target raised by Stifel Nicolaus from $40.00 to $45.00. The firm currently has a buy rating on the stock.
Intellicheck (NASDAQ:IDN) had its price target lowered by DA Davidson from $7.50 to $5.00. The firm currently has a buy rating on the stock.
ITV (LON:ITV) had its price target lowered by JPMorgan Chase & Co. from GBX 85 to GBX 82. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Jernigan Capital (NASDAQ:JCAP) had its target price increased by Citizens Jmp from $26.00 to $28.00. Citizens Jmp currently has a market outperform rating on the stock.
Lithium Americas (NYSE:LAC) had its price target reduced by BMO Capital Markets from $4.50 to $4.00. They currently have a market perform rating on the stock.
LifeStance Health Group (NASDAQ:LFST) had its target price boosted by JPMorgan Chase & Co. from $9.00 to $13.00. The firm currently has a neutral rating on the stock.
LGN (NASDAQ:LGN) had its target price boosted by BMO Capital Markets from $100.00 to $105.00. The firm currently has an outperform rating on the stock.
Intuitive Machines (NASDAQ:LUNR) had its target price cut by Cantor Fitzgerald from $43.00 to $32.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Intuitive Machines (NASDAQ:LUNR) had its target price trimmed by B. Riley Financial, Inc. from $45.00 to $43.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
MeiraGTx (NASDAQ:MGTX) had its target price increased by Royal Bank Of Canada from $26.00 to $27.00. The firm currently has an outperform rating on the stock.
McGraw Hill (NYSE:MH) had its target price raised by BMO Capital Markets from $16.00 to $17.00. The firm currently has an outperform rating on the stock.
Mesa Laboratories (NASDAQ:MLAB) had its price target raised by Wells Fargo & Company from $94.00 to $110.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Merlin, Inc. Common Stock (NASDAQ:MRLN) had its target price reduced by Cantor Fitzgerald from $11.00 to $9.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Madison Square Garden (NYSE:MSGS) had its target price increased by Susquehanna from $430.00 to $477.00. The firm currently has a positive rating on the stock.
Madison Square Garden (NYSE:MSGS) had its price target increased by Guggenheim from $522.00 to $584.00. The firm currently has a buy rating on the stock.
Madison Square Garden (NYSE:MSGS) had its price target increased by JPMorgan Chase & Co. from $450.00 to $485.00. The firm currently has an overweight rating on the stock.
SOLV Energy (NASDAQ:MWH) had its target price cut by Robert W. Baird from $50.00 to $42.00. Robert W. Baird currently has an outperform rating on the stock.
Nkarta (NASDAQ:NKTX) had its price target trimmed by Stifel Nicolaus from $11.00 to $10.00. Stifel Nicolaus currently has a buy rating on the stock.
NU (NYSE:NU) had its price target raised by Needham & Company LLC from $17.00 to $19.00. They currently have a buy rating on the stock.
NextNRG (NASDAQ:NXXT) had its price target reduced by HC Wainwright to $1.50. HC Wainwright currently has a buy rating on the stock.
Oculis (NASDAQ:OCS) had its price target reduced by JPMorgan Chase & Co. from $23.00 to $20.00. They currently have an overweight rating on the stock.
Omada Health (NASDAQ:OMDA) had its target price raised by JPMorgan Chase & Co. from $26.00 to $30.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Omada Health (NASDAQ:OMDA) had its price target increased by Citizens Jmp from $27.00 to $32.00. They currently have a market outperform rating on the stock.
OptimizeRx (NASDAQ:OPRX) had its price target increased by Citizens Jmp from $9.00 to $11.00. Citizens Jmp currently has a market outperform rating on the stock.
Piedmont Realty Trust (NYSE:PDM) had its price target boosted by Robert W. Baird from $9.00 to $10.00. The firm currently has a neutral rating on the stock.
Primary Health Properties (LON:PHP) had its target price raised by Berenberg Bank from GBX 128 to GBX 133. The firm currently has a buy rating on the stock.
Fidelis Insurance (NYSE:PLGO) had its price target lowered by Keefe, Bruyette & Woods from $29.00 to $28.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Powell Industries (NASDAQ:POWL) had its price target cut by Cantor Fitzgerald from $320.00 to $235.00. The firm currently has a neutral rating on the stock.
Relay Therapeutics (NASDAQ:RLAY) had its target price boosted by JPMorgan Chase & Co. from $28.00 to $31.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Sunrun (NASDAQ:RUN) had its target price trimmed by Wells Fargo & Company from $22.00 to $17.00. The firm currently has an overweight rating on the stock.
Securitize (NYSE:SECZ) had its target price reduced by Rosenblatt Securities from $14.00 to $11.00. They currently have a buy rating on the stock.
Sagimet Biosciences (NASDAQ:SGMT) had its price target raised by Citizens Jmp from $12.00 to $29.00. Citizens Jmp currently has a market outperform rating on the stock.
J. M. Smucker (NYSE:SJM) had its price target raised by JPMorgan Chase & Co. from $125.00 to $139.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Smith & Nephew (LON:SN) had its price target lowered by Berenberg Bank from GBX 1,300 to GBX 1,250. The firm currently has a hold rating on the stock.
SoundThinking (NASDAQ:SSTI) had its target price trimmed by Cantor Fitzgerald from $10.00 to $8.00. They currently have a neutral rating on the stock.
Tullow Oil (LON:TLW) had its price target boosted by Canaccord Genuity Group Inc. from GBX 14 to GBX 15. They currently have a hold rating on the stock.
Trevi Therapeutics (NASDAQ:TRVI) had its target price boosted by JonesTrading from $24.00 to $28.00. They currently have a buy rating on the stock.
TSS (NASDAQ:TSSI) had its target price reduced by Needham & Company LLC from $16.00 to $13.00. They currently have a buy rating on the stock.
Touchstone Exploration (LON:TXP) had its target price lowered by Canaccord Genuity Group Inc. from GBX 40 to GBX 32. The firm currently has a speculative buy rating on the stock.
Upstream Bio (NASDAQ:UPB) had its price target raised by JPMorgan Chase & Co. from $8.00 to $9.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Ventas (NYSE:VTR) had its target price raised by Royal Bank Of Canada from $98.00 to $99.00. The firm currently has an outperform rating on the stock.
WBI (NYSE:WBI) had its price target increased by Wells Fargo & Company from $26.00 to $28.00. The firm currently has an equal weight rating on the stock.
Workday (NASDAQ:WDAY) had its target price raised by Robert W. Baird from $190.00 to $215.00. The firm currently has an outperform rating on the stock.
Williams-Sonoma (NYSE:WSM) had its price target boosted by Royal Bank Of Canada from $192.00 to $260.00. They currently have an outperform rating on the stock.
Wolverine World Wide (NYSE:WWW) had its price target boosted by Stifel Nicolaus from $25.00 to $26.00. The firm currently has a buy rating on the stock.
Wolverine World Wide (NYSE:WWW) had its price target boosted by Robert W. Baird from $24.00 to $26.00. Robert W. Baird currently has an outperform rating on the stock.
YETI (NYSE:YETI) had its target price raised by Robert W. Baird from $55.00 to $57.00. Robert W. Baird currently has an outperform rating on the stock.
YETI (NYSE:YETI) had its price target increased by Stifel Nicolaus from $42.00 to $45.00. Stifel Nicolaus currently has a hold rating on the stock.
York Space Systems (NYSE:YSS) had its price target trimmed by Needham & Company LLC from $33.00 to $18.00. They currently have a buy rating on the stock.
Yesway (NASDAQ:YSWY) had its price target increased by JPMorgan Chase & Co. from $25.00 to $27.00. They currently have a neutral rating on the stock.
Receive News & Ratings for Adeia Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adeia Inc and related companies with MarketBeat.com's FREE daily email newsletter.
